Anaphylaxis to piperacillin-tazobactam despite a negative penicillin skin test.
Rank
M A
MA
Park
M A
MA
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications; D003907:Dexamethasone / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007412:Intestinal Fistula / Q000150:complications; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D010406:Penicillins; D010878:Piperacillin / Q000009:adverse effects; D000077725:Piperacillin, Tazobactam Drug Combination; D011237:Predictive Value of Tests; D011852:Radioallergosorbent Test / Q000379:methods; D012882:Skin Tests / Q000379:methods*
D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D010406:Penicillins; D000077725:Piperacillin, Tazobactam Drug Combination; D003907:Dexamethasone; D010397:Penicillanic Acid; D004155:Diphenhydramine; D010878:Piperacillin; D004837:Epinephrine